Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas (Q46403948)

21 December 2017

title

Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas (English)

1 reference

21 December 2017

author

Pamela Russell

6

1 reference

21 December 2017

Christine L. Clarke

object named as

Christine L Clarke

3

0 references

Benita Katzenellenbogen

5

object named as

Benita S Katzenellenbogen

1 reference

21 December 2017

author name string

Morteza Aghmesheh

1

1 reference

21 December 2017

Lyndal Edwards

2

1 reference

21 December 2017

Karen Byth

4

1 reference

21 December 2017

Michael Friedlander

7

1 reference

21 December 2017

Katherine M Tucker

8

1 reference

21 December 2017

Anna de Fazio

9

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

21 December 2017

published in

Gynecologic Oncology

1 reference

21 December 2017

volume

97

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

16-25

1 reference

21 December 2017

Emerging roles of BRCA1 in transcriptional regulation and DNA repair

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Tumour biological features of BRCA1-induced breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Improved survival in women with BRCA-associated ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Hormone therapy in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

An epidemiologic study of epithelial carcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Sex hormones in women in rural China and in Britain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Steroid hormone receptors and long term survival in invasive ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Detection of progesterone receptor forms A and B by immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

BRCA1 mutations in familial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Frequency of BRCA1 dysfunction in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Reduction of BRCA1 expression in sporadic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Absence of estrogen receptor-beta expression in metastatic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Involvement of estrogen receptor beta in ovarian carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.030

10.1016/J.YGYNO.2004.12.030

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017